August 23rd 2024, 3:44pm
Melody Burchett discusses how she educates patients who have been recently diagnosed with uveal melanoma. Resources for Patients With Newly Diagnosed Uveal Melanoma
August 23rd 2024, 3:41pm
Melody Burchett discusses her journey with uveal melanoma and the formation of A Cure in Sight. This program was made possible with support from Immunocore.
August 23rd 2024, 2:43pm
After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from Immunocore.
August 21st 2024, 8:10pm
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
August 21st 2024, 8:03pm
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
August 14th 2024, 6:10pm
Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.
August 14th 2024, 6:04pm
A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
August 10th 2024, 6:00pm
Walking up and down the street a few times a day can help prevent patients with kidney or bladder cancers from becoming deconditioned.
August 8th 2024, 6:19pm
Join us for an Educated Patient® Webinar to explore the essential aspects of radiotherapy as a treatment for cancer, in addition to its various types and practical advice on managing side effects.
August 7th 2024, 6:02pm
Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies that optimize communication when considering treatment options.
My 11-Year Metastatic Breast Cancer Story Defied the Standard Path
Enhertu Combo Improves Progression in HER2+ Metastatic Breast Cancer
Trodelvy Plus Keytruda May Slow Progression in mTNBC
Pausing BTKi for Vaccine Did Not Boost Immunity in CLL